Loading...
Header Logo
Keywords
Last Name
Institution

Alan J. Garber

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Endocrinology
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Biochemistry & Molecular Biology
    DivisionBiochemistry & Molecular Biology

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Cellular Biology
    DivisionMolecular & Cellular Biology


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cosentino F, Ceriello A, Baeres FMM, Fioretto P, Garber A, Stough WG, George JT, Grant PJ, Khunti K, Langkilde AM, Plutzky J, Rydén L, Scheen A, Standl E, Tuomilehto J, Zannad F. Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable. Eur Heart J. 2019 Sep 07; 40(34):2907-2919. PMID: 30445605.
      View in: PubMed
    2. Garber AJ. LETTER TO THE EDITOR. Endocr Pract. 2019 06; 25(6):623. PMID: 31242123.
      View in: PubMed
    3. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY. Endocr Pract. 2019 Jan; 25(1):69-100. PMID: 30742570.
      View in: PubMed
    4. Mechanick JI, Garber AJ, Grunberger G, Handelsman Y, Garvey WT. DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT. Endocr Pract. 2018 Nov; 24(11):995-1011. PMID: 30763128.
      View in: PubMed
    5. Foster JG, Wood SK, Pfeffer MA, DeMets DL, Garber A, Hennekens CH. ASPIRIN FOR PRIMARY PREVENTION IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract. 2018 Oct 02; 24(10):925-927. PMID: 29975578.
      View in: PubMed
    6. Bloomgarden Z, Einhorn D, Handelsman Y, Misra A, Zonszein J, Grunberger G, Jellinger PS, Garber AJ. American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia. J Diabetes. 2018 Aug; 10(8):618-620. PMID: 29655268.
      View in: PubMed
    7. Garber AJ. IN RESPONSE TO AUTHORS' RESPONSE TO KARL Z. NADOLSKY, DO, RE: CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 05; 24(5):499. PMID: 29847169.
      View in: PubMed
    8. Grunberger G, Handelsman Y, Bloomgarden ZT, Fonseca VA, Garber AJ, Haas RA, Roberts VL, Umpierrez GE. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS. Endocr Pract. 2018 Mar; 24(3):302-308. PMID: 29547046.
      View in: PubMed
    9. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY. Endocr Pract. 2018 Jan; 24(1):91-120. PMID: 29368965.
      View in: PubMed
    10. Fonseca VA, Bloomgarden ZT, Dagogo-Jack S, Grunberger G, Einhorn D, Garber AJ, Handelsman Y, Hirsch IB, Umpierrez GE. AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES. Endocr Pract. 2017 Nov; 23(11):1345-1349. PMID: 29190135.
      View in: PubMed
    11. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. Endocr Pract. 2017 Apr; 23(Suppl 2):1-87. PMID: 28437620.
      View in: PubMed
    12. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M, Zangeneh F, Bush MA. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com. Endocr Pract. 2017 Apr 02; 23(4):479-497. PMID: 28156151.
      View in: PubMed
    13. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract. 2017 Feb; 23(2):207-238. PMID: 28095040.
      View in: PubMed
    14. Samson SL, Garber AJ. A Plethora of GLP-1 Agonists: Decisions About What to Use and When. Curr Diab Rep. 2016 12; 16(12):120. PMID: 27766579.
      View in: PubMed
    15. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines. Endocr Pract. 2016 07; 22(7):842-84. PMID: 27472012.
      View in: PubMed
    16. Samson SL, Garber AJ. Prevention of type 2 Diabetes Mellitus: Potential of pharmacological agents. Best Pract Res Clin Endocrinol Metab. 2016 06; 30(3):357-71. PMID: 27432071.
      View in: PubMed
    17. Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, Ferrannini E, Fonseca VA, Garber AJ, Grunberger G, LeRoith D, Umpierrez GE, Weir MR. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS. Endocr Pract. 2016 Jun; 22(6):753-62. PMID: 27082665.
      View in: PubMed
    18. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul; 22 Suppl 3:1-203. PMID: 27219496.
      View in: PubMed
    19. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. Endocr Pract. 2016 Jan; 22(1):84-113. PMID: 26731084.
      View in: PubMed
    20. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY. Endocr Pract. 2015 Dec; 21(12):1403-14. PMID: 26642101.
      View in: PubMed
    21. Gilbert MP, Marre M, Holst JJ, Garber A, Baeres FM, Thomsen H, Pratley RE. COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract. 2016 Apr; 22(4):406-11. PMID: 26574791.
      View in: PubMed
    22. Grunberger G, Bailey T, Camacho PM, Einhorn D, Garber AJ, Handelsman Y, Harrell RM, Lando HM, Law B, Leffert JD, Orzeck EA. Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring. Endocr Pract. 2015 May; 21(5):522-33. PMID: 25962091.
      View in: PubMed
    23. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. AACE/ACE comprehensive diabetes management algorithm 2015. Endocr Pract. 2015 Apr; 21(4):438-47. PMID: 25877012.
      View in: PubMed
    24. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovic L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015 Apr; 21 Suppl 1:1-87. PMID: 25869408.
      View in: PubMed
    25. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovic L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract. 2015 Apr; 21(4):413-37. PMID: 27408942.
      View in: PubMed
    26. Garber AJ. ANTI-OBESITY PHARMACOTHERAPY AND THE POTENTIAL FOR PREVENTING PROGRESSION FROM PREDIABETES TO TYPE 2 DIABETES. Endocr Pract. 2015 Jun; 21(6):634-44. PMID: 25716632.
      View in: PubMed
    27. Garber AJ. Biosimilar products are not bioidentical. J Diabetes. 2015 Mar; 7(2):153-4. PMID: 25395269.
      View in: PubMed
    28. Grunberger G, Garber AJ, Mechanick JI. Obesity management: applying clinical trial data to clinical care. Endocr Pract. 2014 Dec; 20 Suppl 2:6-19. PMID: 25526732.
      View in: PubMed
    29. Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, Grunberger G, Handelsman Y, Hennekens CH, Hurley DL, McGill J, Palumbo P, Umpierrez G. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014 Sep; 20(9):977-89. PMID: 25253227.
      View in: PubMed
    30. Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, Grunberger G, Handelsman Y, Hennekens CH, Hurley DL, McGill J, Palumbo P, Umpierrez G. American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action. Endocr Pract. 2014 Sep; 20(9):956-76. PMID: 25253226.
      View in: PubMed
    31. Mechanick JI, Camacho PM, Garber AJ, Garber JR, Pessah-Pollack R, Petak SM, Tangpricha V, Trence DL. American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists--2014 Update and the AACe G4G Program. Endocr Pract. 2014 Jul; 20(7):692-702. PMID: 25057098.
      View in: PubMed
    32. Garber AJ, Einhorn D, Mechanick JI. AACE Response to viewpoint of December 9, 2013. JAMA Intern Med. 2014 May; 174(5):827. PMID: 24799016.
      View in: PubMed
    33. Hennekens CH, Pfeffer MA, Newcomer JW, Jellinger PS, Garber A. Treatment of diabetes mellitus: the urgent need for multifactorial interventions. Am J Manag Care. 2014 May; 20(5):357-9. PMID: 25181565.
      View in: PubMed
    34. Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation. 2014 Apr 22; 129(16):e460-1. PMID: 24753557.
      View in: PubMed
    35. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar; 43(1):1-23. PMID: 24582089.
      View in: PubMed
    36. Garber AJ. GLP-1 receptor agonists: why is once weekly inferior to once daily? Lancet Diabetes Endocrinol. 2014 Apr; 2(4):266-7. PMID: 24703036.
      View in: PubMed
    37. Garber AJ. The importance of incretin therapies for managing type 2 diabetes. Lancet Diabetes Endocrinol. 2014 Feb; 2(2):95-7. PMID: 24622701.
      View in: PubMed
    38. Garber AJ, Newcomer JW, Hennekens CH. Lower A1c targets in type 2 diabetes and increased mortality: causal or casual? Am J Med. 2013 Dec; 126(12):1033-4. PMID: 24035125.
      View in: PubMed
    39. Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2013 Aug 20; 128(8):785-94. PMID: 23857320.
      View in: PubMed
    40. Garber AJ. In response. Endocr Pract. 2013 Jul-Aug; 19(4):737. PMID: 24137733.
      View in: PubMed
    41. Tamez-Pérez HE, Proskauer-Peña SL, Hernrndez-Coria MI, Garber AJ. AACE Comprehensive Diabetes Management Algorithm 2013. Endocrine Practice. Endocr Pract. 2013 Jul-Aug; 19(4):736-7. PMID: 23807530.
      View in: PubMed
    42. Handelsman Y, Leroith D, Bloomgarden ZT, Dagogo-Jack S, Einhorn D, Garber AJ, Grunberger G, Harrell RM, Gagel RF, Lebovitz HE, McGill JB, Hennekens CH. Diabetes and cancer--an AACE/ACE consensus statement. Endocr Pract. 2013 Jul-Aug; 19(4):675-93. PMID: 23978590.
      View in: PubMed
    43. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE, Davidson MH. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract. 2013 May-Jun; 19(3):536-57. PMID: 23816937.
      View in: PubMed
    44. Samson SL, Garber A. GLP-1R agonist therapy for diabetes: benefits and potential risks. Curr Opin Endocrinol Diabetes Obes. 2013 Apr; 20(2):87-97. PMID: 23403741.
      View in: PubMed
    45. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, Davidson MB, Einhorn D, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez G, Davidson MH. AACE comprehensive diabetes management algorithm 2013. Endocr Pract. 2013 Mar-Apr; 19(2):327-36. PMID: 23598536.
      View in: PubMed
    46. Garber AJ. Methods to enhance delivery of prandial insulin and basal-prandial insulin. Diabetes Obes Metab. 2013 Mar; 15 Suppl 1:11-7. PMID: 23448198.
      View in: PubMed
    47. Handelsman Y, Oral EA, Bloomgarden ZT, Brown RJ, Chan JL, Einhorn D, Garber AJ, Garg A, Garvey WT, Grunberger G, Henry RR, Lavin N, Tapiador CD, Weyer C. The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract. 2013 Jan-Feb; 19(1):107-16. PMID: 23435042.
      View in: PubMed
    48. Mechanick JI, Garber AJ, Handlesman Y, Garvey WT, McMahon MM, Hurley DL. In response. Endocr Pract. 2013 Jan-Feb; 19(1):170. PMID: 24386668.
      View in: PubMed
    49. Garber AJ, Blonde L, Bloomgarden ZT, Handelsman Y, Dagogo-Jack S. The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendations. Endocr Pract. 2013 Jan-Feb; 19(1):100-6. PMID: 23337160.
      View in: PubMed
    50. Bloomgarden ZT, Blonde L, Garber AJ, Wysham CH. Current issues in GLP-1 receptor agonist therapy for type 2 diabetes. Endocr Pract. 2012 Nov-Dec; 18 Suppl 3:6-26; quiz 27-8. PMID: 23315305.
      View in: PubMed
    51. Garber AJ, Repas T, Kruger DF, Alamia R. Building a solid foundation in diabetes: the nuts and bolts of insulin therapy. Am J Med. 2012 Nov; 125(11):S1-2. PMID: 23098875.
      View in: PubMed
    52. Brooks MM, Chaitman BR, Nesto RW, Hardison RM, Feit F, Gersh BJ, Krone RJ, Sako EY, Rogers WJ, Garber AJ, King SB, Davidson CJ, Ikeno F, Frye RL. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2012 Oct 23; 126(17):2115-24. PMID: 23008442.
      View in: PubMed
    53. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract. 2012 Sep-Oct; 18(5):642-8. PMID: 23047927.
      View in: PubMed
    54. Garber AJ. Postprandial dysmetabolism and the heart. Heart Fail Clin. 2012 Oct; 8(4):563-73. PMID: 22999240.
      View in: PubMed
    55. Pratley RE, Nauck MA, Bailey T, Montanya E, Filetti S, Garber AJ, Thomsen AB, Furber S, Davies M. Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial. Diabetes Care. 2012 Oct; 35(10):1986-93. PMID: 22851600.
      View in: PubMed
    56. Garber AJ. Hypoglycaemia: a therapeutic concern in type 2 diabetes. Lancet. 2012 Jun 16; 379(9833):2215-6. PMID: 22704156.
      View in: PubMed
    57. Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, Rosenstock J, Endahl LA, Francisco AM, Hollander P. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet. 2012 Apr 21; 379(9825):1498-507. PMID: 22521072.
      View in: PubMed
    58. Garber AJ. Novel GLP-1 receptor agonists for diabetes. Expert Opin Investig Drugs. 2012 Jan; 21(1):45-57. PMID: 22111970.
      View in: PubMed
    59. Garber AJ. Incretin therapy--present and future. Rev Diabet Stud. 2011; 8(3):307-22. PMID: 22262069.
      View in: PubMed
    60. Sharma MD, Farmer JA, Garber A. Type 2 diabetes and cardiovascular risk factors. Curr Med Res Opin. 2011 Nov; 27 Suppl 3:1-5. PMID: 22106974.
      View in: PubMed
    61. Garber AJ. Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients with type 2 diabetes mellitus. J Am Osteopath Assoc. 2011 Jul; 111(7 Suppl 5):S20-30. PMID: 21813733.
      View in: PubMed
    62. Garber AJ. Incretin effects on ß-cell function, replication, and mass: the human perspective. Diabetes Care. 2011 May; 34 Suppl 2:S258-63. PMID: 21525465.
      View in: PubMed
    63. Garber AJ. Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability. Diabetes Care. 2011 May; 34 Suppl 2:S279-84. PMID: 21525469.
      View in: PubMed
    64. Garber AJ. Hypertension and lipid management in prediabetic states. J Clin Hypertens (Greenwich). 2011 Apr; 13(4):270-4. PMID: 21466625.
      View in: PubMed
    65. Buse JB, Garber A, Rosenstock J, Schmidt WE, Brett JH, Videbæk N, Holst J, Nauck M. Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials. J Clin Endocrinol Metab. 2011 Jun; 96(6):1695-702. PMID: 21450987.
      View in: PubMed
    66. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovic L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011 Mar-Apr; 17 Suppl 2:1-53. PMID: 21474420.
      View in: PubMed
    67. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovic L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011 Mar-Apr; 17(2):287-302. PMID: 21474421.
      View in: PubMed
    68. Garber AJ. Incretin-based therapies in the management of type 2 diabetes: rationale and reality in a managed care setting. Am J Manag Care. 2010 Aug; 16(7 Suppl):S187-94. PMID: 20809667.
      View in: PubMed
    69. Mechanick JI, Camacho PM, Cobin RH, Garber AJ, Garber JR, Gharib H, Petak SM, Rodbard HW, Trence DL. American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. Endocr Pract. 2010 Mar-Apr; 16(2):270-83. PMID: 20350905.
      View in: PubMed
    70. Nauck MA, Vilsbøll T, Gallwitz B, Garber A, Madsbad S. Incretin-based therapies: viewpoints on the way to consensus. Diabetes Care. 2009 Nov; 32 Suppl 2:S223-31. PMID: 19875556.
      View in: PubMed
    71. Garber AJ. Combined pharmacologic/nonpharmacologic intervention in individuals at high risk of developing type 2 diabetes: pro pharmacologic therapy. Diabetes Care. 2009 Nov; 32 Suppl 2:S184-8. PMID: 19875549.
      View in: PubMed
    72. Sharma MD, Garber AJ. What is the best treatment for prediabetes? Curr Diab Rep. 2009 Oct; 9(5):335-41. PMID: 19793502.
      View in: PubMed
    73. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009 Sep-Oct; 15(6):540-59. PMID: 19858063.
      View in: PubMed
    74. DeFronzo RA, Hissa MN, Garber AJ, Luiz Gross J, Yuyan Duan R, Ravichandran S, Chen RS. The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone. Diabetes Care. 2009 Sep; 32(9):1649-55. PMID: 19478198.
      View in: PubMed
    75. Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, Garvey WT, Gavin JR, Grunberger G, Horton ES, Jellinger PS, Jones KL, Lebovitz H, Levy P, McGuire DK, Moghissi ES, Nesto RW. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008 Oct; 14(7):933-46. PMID: 18996826.
      View in: PubMed
    76. Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet. 2009 Feb 07; 373(9662):473-81. PMID: 18819705.
      View in: PubMed
    77. Garber AJ, Spann SJ. An overview of incretin clinical trials. J Fam Pract. 2008 Sep; 57(9 Suppl):S10-8. PMID: 18786339.
      View in: PubMed
    78. Sharma SK, Yeo JP, Garber A. Lessons in initiating insulin in clinical practice. Diabetes Res Clin Pract. 2008 Sep; 81 Suppl 1:S16-22. PMID: 18672308.
      View in: PubMed
    79. Sharma MD, Garber AJ, Farmer JA. Role of insulin signaling in maintaining energy homeostasis. Endocr Pract. 2008 Apr; 14(3):373-80. PMID: 18463047.
      View in: PubMed
    80. Garber AJ, Sharma MD. Update: vildagliptin for the treatment of Type 2 diabetes. Expert Opin Investig Drugs. 2008 Jan; 17(1):105-13. PMID: 18095923.
      View in: PubMed
    81. Garber AJ, Clauson P, Pedersen CB, Kølendorf K. Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trials. J Am Geriatr Soc. 2007 Nov; 55(11):1735-40. PMID: 17979896.
      View in: PubMed
    82. Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab. 2007 Sep; 9(5):630-9. PMID: 17697056.
      View in: PubMed
    83. Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ. Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin. Diabetes Care. 2007 Apr; 30(4):890-5. PMID: 17277036.
      View in: PubMed
    84. Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ. Basal insulin or premix analogue therapy in type 2 diabetes patients. Eur J Intern Med. 2007 Jan; 18(1):56-62. PMID: 17223044.
      View in: PubMed
    85. Davidson MH, Basile J, Garber AJ, Phillips RA. Reducing the risk of stroke through appropriate targets and treatments. Prev Cardiol. 2007; 10(4):215-21. PMID: 17917519.
      View in: PubMed
    86. Garber AJ. New standards to reduce morbidity and mortality in hospitalized patients with diabetes. Am Fam Physician. 2006 Feb 15; 73(4):591, 594. PMID: 16506704.
      View in: PubMed
    87. Gotto AM, Blackburn GL, Dailey GE, Garber AJ, Grundy SM, Sobel BE, Weir MR. The metabolic syndrome: a call to action. Coron Artery Dis. 2006 Feb; 17(1):77-80. PMID: 16374146.
      View in: PubMed
    88. Garber AJ. Premixed insulin analogues for the treatment of diabetes mellitus. Drugs. 2006; 66(1):31-49. PMID: 16398567.
      View in: PubMed
    89. Vasudevan AR, Garber AJ. Diabetic dyslipidemia and the heart. Heart Fail Clin. 2006 Jan; 2(1):37-52. PMID: 17386875.
      View in: PubMed
    90. Garber AJ. Pharmacologic modifications of hormones to improve their therapeutic potential for diabetes management. Diabetes Obes Metab. 2005 Nov; 7(6):666-74. PMID: 16219010.
      View in: PubMed
    91. Bryer-Ash M, Garber AJ. Point: Inpatient glucose management: the emperor finally has clothes. Diabetes Care. 2005 Apr; 28(4):973-5. PMID: 15793209.
      View in: PubMed
    92. Garber AJ. Cardiovascular risk and diabetes mellitus management: diagnosis and treatment in special patient populations. Introduction. Am J Med. 2005 Apr; 118 Suppl 2:1S-2S. PMID: 15903288.
      View in: PubMed
    93. Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005 Feb; 28(2):260-5. PMID: 15677776.
      View in: PubMed
    94. Garber AJ. Assessing the role of biphasic insulin aspart 30 as an effective and tolerable front-line therapy for type 2 diabetes. Clin Ther. 2005; 27 Suppl B:S39-41. PMID: 16519036.
      View in: PubMed
    95. Huang AJ, Gemperli MP, Bergthold L, Singer SS, Garber A. Health plans' coverage determinations for technology-based interventions: the case of electrical bone growth stimulation. Am J Manag Care. 2004 Dec; 10(12):957-62. PMID: 15617371.
      View in: PubMed
    96. Garber AJ. The metabolic syndrome. Med Clin North Am. 2004 Jul; 88(4):837-46, ix. PMID: 15308381.
      View in: PubMed
    97. Garber AJ, Moghissi ES, Bransome ED, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004 Mar-Apr; 10 Suppl 2:4-9. PMID: 15251633.
      View in: PubMed
    98. Garber AJ, Seidel J, Armbruster M. Current standards of care for inpatient glycemic management and metabolic control: is it time for definite standards and targets? Endocr Pract. 2004 Mar-Apr; 10 Suppl 2:10-2. PMID: 15251634.
      View in: PubMed
    99. Goss JA, Goodpastor SE, Brunicardi FC, Barth MH, Soltes GD, Garber AJ, Hamilton DJ, Alejandro R, Ricordi C. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation. 2004 Feb 15; 77(3):462-6. PMID: 14966428.
      View in: PubMed
    100. Garber AJ, Moghissi ES, Bransome ED, Clark NG, Clement S, Cobin RH, Furnary AP, Hirsch IB, Levy P, Roberts R, Van den Berghe G, Zamudio V. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004 Jan-Feb; 10(1):77-82. PMID: 15251626.
      View in: PubMed
    101. Garber AJ, Donovan DS, Dandona P, Bruce S, Park JS. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. J Clin Endocrinol Metab. 2003 Aug; 88(8):3598-604. PMID: 12915642.
      View in: PubMed
    102. Garber AJ. Benefits of combination therapy of insulin and oral hypoglycemic agents. Arch Intern Med. 2003 Aug 11-25; 163(15):1781-2. PMID: 12912710.
      View in: PubMed
    103. Garber AJ. Cardiovascular complications of diabetes: prevention and management. Clin Cornerstone. 2003; 5(2):22-37. PMID: 12800478.
      View in: PubMed
    104. Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation. 2002 Dec 27; 74(12):1761-6. PMID: 12499894.
      View in: PubMed
    105. Garber AJ, Bruce S, Fiedorek FT. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study. Clin Ther. 2002 Sep; 24(9):1401-13. PMID: 12380632.
      View in: PubMed
    106. Grundy SM, Garber A, Goldberg R, Havas S, Holman R, Lamendola C, Howard WJ, Savage P, Sowers J, Vega GL. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation. 2002 May 07; 105(18):e153-8. PMID: 11994266.
      View in: PubMed
    107. Garber AJ. Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab. 2002 Jan; 4 Suppl 1:S5-12. PMID: 11843949.
      View in: PubMed
    Garber's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description